India
oi-Vicky Nanjappa
New Delhi, May 14: The ongoing vaccine crisis in India is expected to continue at least for another three months. The Centre was expecting availability of over 200 crore doses of vaccine between August and December and this would include 75 crore doses of Covishield and 55 crore doses of Covaxin.
Biological Evans Sub Unit vaccine (30 crore dose), Zydus Cadila DNA vaccine (5 crore), SII-Novavax vaccine (20 crore), Bharat Biotech’s nasal vaccine (10 crore), Genova mRNA vaccine (6 crore) and Sputnik V (15.6 crore) are the other vaccines likely to hit the Indian market in the second half of 2021.
On day 177 India’s cumulative vaccine coverage exceeds 17.70 crore doses
Niti Aayog Member, Vinod Paul said that Sputnik-V will be available in the market from next week. Russia has committed that it would provide 6 million doses of ready to administer Sputnik-V in May.
Paul said that the…
